Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201506001158296Completed
Trial of dexmedetomidine and bupivacaine (2 arms), sponsored by diab fuad hetta. Primary endpoint: Rate of success of the block. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201506001158296.